Randall F. Holcombe, MD, MBA, Named UVM Cancer Center Director & Hematology/Oncology Division Chief
Randall F. Holcombe, M.D., M.B.A. (Courtesy photo)The Larner College of Medicine at the University of Vermont (UVM), in collaboration with the UVM Health Network (UVMHN) and the UVM Medical Center, has announced that Randall F. Holcombe, M.D., M.B.A., has been appointed director of the UVM Cancer Center
(UVMCC) and chief of the Division of Hematology and Oncology in the Department of Medicine. Holcombe is expected to hold the newly established J. Walter Juckett Chair in Cancer Research. He joins UVM and UVMHN from the National Cancer Institute (NCI)-designated
University of Hawai'i Cancer Center, where he has held the post of director since 2016. He succeeds Richard Galbraith, M.D., Ph.D., and Chris Holmes, M.D., Ph.D., who became interim co-directors of UVMCC in 2020, with Holmes also serving as interim
chief of the Division of Hematology and Oncology since 2017. Holcombe will officially begin his tenure August 1, 2021. View the full article here.